Predicting total nucleic acid yield and dissection boundaries for histology slides

US11348239B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11348239-B2
Application numberUS-202017139784-A
CountryUS
Kind codeB2
Filing dateDec 31, 2020
Priority dateMay 14, 2018
Publication dateMay 31, 2022
Grant dateMay 31, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for determining tumor block sufficiency for generating one or more hematoxylin and eosin (H&E) slides by assessing an expected yield of nucleic acids for tumor cells and determining a number of H&E slide for satisfying a desired total nucleic yield is provided.

First claim

Opening claim text (preview).

What is claimed: 1. A computer-implemented method comprising: receiving a first hematoxylin and eosin (H&E) slide prepared from a tumor block at an image-based nucleic acid yield prediction system having one or more processors; identifying, using the one or more processors, tumor cells of the H&E slide from a digital image; generating a tumor area mask based at least in part on the identified tumor cells, wherein the tumor area mask defines a dissection boundary of the H&E slide associated with the digital image; predicting an expected yield of nucleic acid for the tumor cells within the dissection boundary, by providing the digital image to a machine learning model trained on a plurality of H&E slides having labeled dissection boundaries and labeled total nucleic yield; based on the predicted expected yield of nucleic acid, identifying a number of H&E slides to prepare from the tumor block to satisfy a total nucleic yield; and preparing the number of H&E slides from the tumor block when the predicted expected yield of nucleic acid exceeds a predetermined threshold. 2. The method of claim 1 , wherein the predetermined threshold is based at least in part on one or more specification requirements. 3. The method of claim 2 , wherein specification requirements are based on a minimum surface area within the dissection boundary. 4. The method of claim 2 , wherein specification requirements are based on a minimum cell count within the dissection boundary. 5. The method of claim 2 , wherein specification requirements are based on a minimum cell density within the dissection boundary. 6. The method of claim 2 , wherein specification requirements are set by an entity. 7. The method of claim 1 , wherein the predetermined threshold is selected from a range between and including 50 ng-2000 ng. 8. The method of claim 1 , wherein predicting the expected yield of nucleic acid for the tumor cells within the dissection boundary comprises: counting the number of tumor cells identified within the dissection boundary and multiplying the count by a tumor cell average nucleic acid yield. 9. The method of claim 1 , wherein predicting the expected yield of nucleic acid for the tumor cells within the dissection boundary comprises: calculating the surface area of the dissection boundary and multiplying the surface area by a dissection boundary average nucleic acid yield. 10. The method of claim 1 , wherein the dissection boundary is a microdissection boundary. 11. The method of claim 1 , wherein the dissection boundary is a macrodissection boundary. 12. The method of claim 1 , wherein the dissection boundary is a whole slide boundary. 13. The method of claim 1 , wherein identifying the tumor cells of the H&E slide from the digital image comprises identifying the tumor cells using a trained cell segmentation model. 14. The method of claim 13 , wherein identifying the tumor using the trained cell segmentation model comprises: applying, using the one or more processors, a plurality of tile images formed from the digital image to the trained cell segmentation model and, for each tile, assigning a cell classification to one or more pixels within the tile image. 15. The method of claim 14 , wherein assigning the cell classification to one or more pixels within the tile image comprises: identifying, using the one or more processors, the one or more pixels as a cell interior, a cell border, or a cell exterior and classifying the one or more pixels as the cell interior, the cell border, or the cell exterior. 16. The method of claim 13 , wherein the trained cell segmentation model is a pixel-resolution three-dimensional UNet classification model trained to classify a cell interior, a cell border, and a cell exterior. 17. The method of claim 13 , wherein identifying the tumor cells using the trained cell segmentation model comprises: applying, using the one or more processors, each of a plurality of tile images formed from the digital image to the trained cell segmentation model; and performing, using the one or more processors, a registration on segmented cells in each of the tile images by determining a cell border of each cell, determining a centroid of each cell, and shifting coordinates of centroids to a universal coordinate space for the digital image. 18. The method of claim 13 , wherein the trained cell segmentation model is trained using a set of H&E slide training images annotated with identified cell borders, identified cell interiors, and identified cell exteriors. 19. The method of claim 1 , further comprising superimposing, using a viewer, the tumor area mask over the digital image to visually indicate to a user which tumor cells to scrape. 20. The method of claim 1 , wherein generating the tumor area mask further comprises providing the digital image of the H&E slide to a model trained on a plurality of H&E slides having dissection labels. 21. A system comprising a pathology slide scanner system configured to perform the method of claim 1 . 22. The system of claim 21 , further configured to generate a digital image of each of the one or more H&E slides from the tumor block. 23. The system of claim 22 , wherein the pathology slide scanner system is communicatively coupled to an image-based tumor cells prediction system through a communication network for providing the one or more of digital images. 24. The method of claim 1 , wherein the one or more processors are one or more graphics processing units (GPUs), tensor processing units (TPUs), and/or central processing units (CPUs). 25. The method of claim 1 , wherein the expected yield of nucleic acid is confirmed through sequencing the tumor cells within the dissection boundary. 26. The method of claim 25 , where sequencing is next-generation sequencing. 27. The method of claim 25 , where sequencing is short-read sequencing.

Assignees

Inventors

Classifications

  • G06T1/20Primary

    Processor architectures; Processor configuration, e.g. pipelining · CPC title

  • Local feature extraction by analysis of parts of the pattern, e.g. by detecting edges, contours, loops, corners, strokes or intersections; Connectivity analysis, e.g. of connected components · CPC title

  • using classification, e.g. of video objects · CPC title

  • G06T7/0012Primary

    Biomedical image inspection · CPC title

  • Probabilistic graphical models, e.g. probabilistic networks · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11348239B2 cover?
A method for determining tumor block sufficiency for generating one or more hematoxylin and eosin (H&E) slides by assessing an expected yield of nucleic acids for tumor cells and determining a number of H&E slide for satisfying a desired total nucleic yield is provided.
Who is the assignee on this patent?
Tempus Labs Inc
What technology area does this patent fall under?
Primary CPC classification G06T1/20. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).